# DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR FERRET BIOMARKERS

> **NIH NIH N43** · AVANTGEN, INC. · 2021 · $356,021

## Abstract

This project is to generate and characterize rabbit monoclonal antibodies (mAbs) against five ferret biomarkers, focusing on inflammatory cytokines produced following immune activation in ferrets. Generated mAbs will undergo extensive immunological characterization. The successful completion of this project will address an urgent need for specific and sensitive reagents capable of measuring cytokine responses in the ferret model for infectious disease and immunology research.

## Key facts

- **NIH application ID:** 10470554
- **Project number:** 75N93021C00040-0-9999-1
- **Recipient organization:** AVANTGEN, INC.
- **Principal Investigator:** XIAOMIN FAN
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $356,021
- **Award type:** —
- **Project period:** 2021-08-01 → 2023-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10470554

## Citation

> US National Institutes of Health, RePORTER application 10470554, DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR FERRET BIOMARKERS (75N93021C00040-0-9999-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10470554. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*